Daniel Skovronsky - Feb 1, 2022 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
SVP, CS&MO & Pres. LRL
Signature
/s/ Jonathan Groff for Daniel Skovronsky, authorization on file
Stock symbol
LLY
Transactions as of
Feb 1, 2022
Transactions value $
-$2,070,355
Form type
4
Date filed
2/3/2022, 03:50 PM
Previous filing
Feb 3, 2022
Next filing
Feb 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Options Exercise $0 +18.7K +41.01% $0.00 64.4K Feb 1, 2022 Direct
transaction LLY Common Stock Tax liability -$2.07M -8.44K -13.1% $245.39 56K Feb 1, 2022 Direct
holding LLY Common Stock 70K Feb 1, 2022 By Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LLY Restricted Stock Unit Options Exercise $0 -18.7K -100% $0.00* 0 Feb 1, 2022 Common Stock 18.7K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F2 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.